Abstract
Clinical dementia research is dependent on measurements that can detect variable signals amid the noise of clinical variation and uncertainty. In the past year, we have seen attempts to define these signals for the diagnosis and prediction of dementia, measurement of outcomes in clinical trials, and definition of important risk factors in epidemiological studies. Advances in each of these areas have come through the development of new technologies or through the study of large groups of patients with new approaches.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
